Human leukocyte antigen (HLA) class I down-regulation by human immunodeficiency virus type 1 negative factor (HIV-1 Nef): what might we learn from natural sequence variants?

Viruses. 2012 Sep;4(9):1711-30. doi: 10.3390/v4091711. Epub 2012 Sep 24.

Abstract

HIV-1 causes a chronic infection in humans that is characterized by high plasma viremia, progressive loss of CD4+ T lymphocytes, and severe immunodeficiency resulting in opportunistic disease and AIDS. Viral persistence is mediated in part by the ability of the Nef protein to down-regulate HLA molecules on the infected cell surface, thereby allowing HIV-1 to evade recognition by antiviral CD8+ T lymphocytes. Extensive research has been conducted on Nef to determine protein domains that are required for its immune evasion activities and to identify critical cellular co-factors, and our mechanistic understanding of this process is becoming more complete. This review highlights our current knowledge of Nef-mediated HLA class I down-regulation and places this work in the context of naturally occurring sequence variation in this protein. We argue that efforts to fully understand the critical role of Nef for HIV-1 pathogenesis will require greater analysis of patient-derived sequences to elucidate subtle differences in immune evasion activity that may alter clinical outcome.

Keywords: HIV-1; HLA class I; Nef; cytotoxic T lymphocyte; host immune selection pressure; immune evasion; viral sequence diversity.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • CD8-Positive T-Lymphocytes / immunology
  • Down-Regulation*
  • Genetic Variation*
  • HIV-1 / pathogenicity*
  • Histocompatibility Antigens Class I / biosynthesis*
  • Humans
  • Immune Evasion
  • Virulence Factors / genetics
  • Virulence Factors / metabolism*
  • nef Gene Products, Human Immunodeficiency Virus / genetics
  • nef Gene Products, Human Immunodeficiency Virus / metabolism*

Substances

  • Histocompatibility Antigens Class I
  • Virulence Factors
  • nef Gene Products, Human Immunodeficiency Virus
  • nef protein, Human immunodeficiency virus 1

Grants and funding